BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37906138)

  • 1. [Genetic analysis of two cases with MYC "negative" Burkitt lymphoma].
    Lyu R; Zheng Y; An G; Li C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Nov; 40(11):1340-1344. PubMed ID: 37906138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of interphase fluorescence in situ Hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas.
    Siebert R; Matthiesen P; Harder S; Zhang Y; Borowski A; Zühlke-Jenisch R; Metzke S; Joos S; Weber-Matthiesen K; Grote W; Schlegelberger B
    Blood; 1998 Feb; 91(3):984-90. PubMed ID: 9446660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection.
    Muñoz-Mármol AM; Sanz C; Tapia G; Marginet R; Ariza A; Mate JL
    Histopathology; 2013 Sep; 63(3):418-24. PubMed ID: 23795946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
    Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
    [No Abstract]   [Full Text] [Related]  

  • 5. Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.
    Woroniecka R; Rymkiewicz G; Szafron LM; Blachnio K; Szafron LA; Bystydzienski Z; Pienkowska-Grela B; Borkowska K; Rygier J; Kotyl A; Malawska N; Wojtkowska K; Parada J; Borysiuk A; Murcia Pienkowski V; Rydzanicz M; Grygalewicz B
    PLoS One; 2022; 17(2):e0263980. PubMed ID: 35167621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkitt lymphoma: interpreting FISH testing for
    Sharma P; Singal S; Costello P; Krishnan K
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35135797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis.
    Mossafa H; Damotte D; Jenabian A; Delarue R; Vincenneau A; Amouroux I; Jeandel R; Khoury E; Martelli JM; Samson T; Tapia S; Flandrin G; Troussard X
    Leuk Lymphoma; 2006 Sep; 47(9):1885-93. PubMed ID: 17065002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature.
    Reddy K; Satyadev R; Bouman D; Hibbard MK; Lu G; Paolo R
    Cancer Genet Cytogenet; 2006 Apr; 166(1):12-21. PubMed ID: 16616107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
    Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
    J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
    De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
    Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.
    Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ
    Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of myc translocations in lymphoma cells by fluorescence in situ hybridization with yeast artificial chromosomes.
    Veronese ML; Ohta M; Finan J; Nowell PC; Croce CM
    Blood; 1995 Apr; 85(8):2132-8. PubMed ID: 7718884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions.
    Haralambieva E; Schuuring E; Rosati S; van Noesel C; Jansen P; Appel I; Guikema J; Wabinga H; Bleggi-Torres LF; Lam K; van den Berg E; Mellink C; van Zelderen-Bhola S; Kluin P
    Genes Chromosomes Cancer; 2004 May; 40(1):10-8. PubMed ID: 15034863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological and molecular genetic features of Burkitt-like lymphoma with 11q aberration].
    Zhang YP; Zhang L; Zhang DD; Wang GN; Zhao WG; Jian XY; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):604-608. PubMed ID: 34078047
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.
    Aukema SM; Theil L; Rohde M; Bauer B; Bradtke J; Burkhardt B; Bonn BR; Claviez A; Gattenlöhner S; Makarova O; Nagel I; Oschlies I; Pott C; Szczepanowski M; Traulsen A; Kluin PM; Klapper W; Siebert R; Murga Penas EM
    Br J Haematol; 2015 Sep; 170(6):814-25. PubMed ID: 26104998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel three-break rearrangement and cryptic translocations leading to colocalization of MYC and IGH signals in B-cell acute lymphoblastic leukemia.
    Tchinda J; Volpert S; Berdel WE; Büchner T; Horst J
    Cancer Genet Cytogenet; 2006 Mar; 165(2):180-4. PubMed ID: 16527615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of 2016 WHO classification in the diagnosis of paediatric high-grade
    Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W
    J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.